Apocynin improving cardiac remodeling in chronic renal failure disease is associated with up-regulation of epoxyeicosatrienoic acids

Oncotarget
Kun ZhangHui Huang

Abstract

Cardiac remodeling is one of the most common cardiac abnormalities and associated with a high mortality in chronic renal failure (CRF) patients. Apocynin, a nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase inhibitor, has been showed cardio-protective effects. However, whether apocynin can improve cardiac remodeling in CRF and what is the underlying mechanism are unclear. In the present study, we enrolled 94 participants. In addition, we used 5/6 nephrectomized rats to mimic cardiac remodeling in CRF. Serum levels of epoxyeicosatrienoic acids (EETs) and its mainly metabolic enzyme-soluble epoxide hydrolase (sEH) were measured. The results showed that the serum levels of EETs were significantly decreased in renocardiac syndrome participants (P < 0.05). In 5/6 nephrectomized CRF model, the ratio of left ventricular weight / body weight, left ventricular posterior wall thickness, and cardiac interstitial fibrosis were significantly increased while ejection fraction significantly decreased (P < 0.05). All these effects could partly be reversed by apocynin. Meanwhile, we found during the process of cardiac remodeling in CRF, apocynin significantly increased the reduced serum levels of EETs and decreased the mRNA and protei...Continue Reading

References

Dec 31, 2003·Biochemical and Biophysical Research Communications·Young Mee ParkJeong Bae Park
Mar 3, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Vincenzo PanichiCiro Tetta
Jun 2, 2006·Journal of the American Society of Nephrology : JASN·Marcello TonelliAmit X Garg
Sep 22, 2006·American Journal of Physiology. Cell Physiology·Arthur A Spector, Andrew W Norris
Nov 30, 2006·Proceedings of the National Academy of Sciences of the United States of America·Danyan XuNipavan Chiamvimonvat
Nov 14, 2008·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Sophie GoulitquerDanièle Lucas
Nov 15, 2008·Journal of the American College of Cardiology·Claudio RoncoRinaldo Bellomo
Jan 8, 2009·Proceedings of the National Academy of Sciences of the United States of America·Ding AiYi Zhu
Feb 4, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Hideki FujiiMasafumi Fukagawa
Jul 24, 2010·Canadian Journal of Physiology and Pharmacology·Jinjun LiuWeijin Zang
Jul 15, 2011·American Journal of Physiology. Renal Physiology·Kathryn M GauthierWilliam B Campbell
Nov 26, 2011·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Ahmed A Elmarakby
Feb 3, 2012·Physiological Reviews·John D Imig
Mar 20, 2013·Journal of Translational Medicine·Kun ZhangHui Huang
Nov 29, 2013·American Journal of Physiology. Renal Physiology·Jie ZhangRuisheng Liu
Jul 26, 2014·Journal of Physiology and Biochemistry·Kyaw Thu MoeMeng Cheong Wong

❮ Previous
Next ❯

Citations

Nov 5, 2017·American Journal of Physiology. Heart and Circulatory Physiology·Weijing FengHui Huang
Jun 21, 2020·Physiological Reports·Benjamin GollaschFriedrich C Luft

❮ Previous
Next ❯

Software Mentioned

SPSS
Image Pro - plus

Related Concepts

Related Feeds

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.